Tag: Tofacitinib

While the term 'Jack tablet' is not a recognized pharmaceutical product, it is most likely a common mishearing of 'JAK tablet' or 'JAK inhibitor.' These medications, such as tofacitinib (sold under the brand name Xeljanz), belong to a crucial class of drugs known as Janus kinase inhibitors, which modulate the immune system to treat a variety of autoimmune and inflammatory diseases. This article will clarify the function and uses of these powerful immunosuppressants.

In 2014, a case report was among the first to demonstrate that the Janus kinase (JAK) inhibitor **tofacitinib** could successfully treat alopecia areata, an autoimmune hair loss condition. While not specifically FDA-approved for hair growth, this medication is widely used off-label by dermatologists to help patients experiencing significant hair loss.

The landscape of rheumatoid arthritis treatment has seen significant evolution, moving from broad-spectrum immunosuppressants to targeted therapies. Today, new oral medications offer a convenient alternative to traditional injectables. So, what is the new pill for rheumatoid arthritis that is providing better options for patients?

Tofashine XR 11mg, a brand of the Janus kinase (JAK) inhibitor tofacitinib, is prescribed to treat a range of moderate to severe autoimmune conditions in adults who have not responded well to other therapies. It works by targeting specific enzymes within the immune system to help reduce inflammation.

As a type of Janus kinase (JAK) inhibitor, the drug Xeltin (tofacitinib) works by modulating the body's immune system to reduce inflammation in patients with specific autoimmune conditions. This medication is most commonly prescribed for adults who have not responded adequately to or cannot tolerate other, first-line treatments for their condition.